4.7 Review

Modulation of Macrophages M1/M2 Polarization Using Carbohydrate-Functionalized Polymeric Nanoparticles

Journal

POLYMERS
Volume 13, Issue 1, Pages -

Publisher

MDPI
DOI: 10.3390/polym13010088

Keywords

glyconanoparticles; immunotherapy; infectious diseases; mannose receptors; nutraceuticals

Funding

  1. PT national funds by FCT-Foundation for Science and Technology [COMPETE POCI-01-0145-FEDER-030834]
  2. National Funds (FCT) [PTDC/QUI-COL/30834/2017]
  3. Fundação para a Ciência e a Tecnologia [PTDC/QUI-COL/30834/2017] Funding Source: FCT

Ask authors/readers for more resources

The use of carbohydrate-conjugated nanocarriers to target macrophages allows for modulation of inflammatory responses and tissue repair through alterations in phenotypic polarization. This approach offers new targeting strategies for infectious diseases, cancer immunotherapy, and prevention. Further research is needed to elucidate the interaction mechanism between nanocarriers and macrophages for clinical applications.
Exploiting surface endocytosis receptors using carbohydrate-conjugated nanocarriers brings outstanding approaches to an efficient delivery towards a specific target. Macrophages are cells of innate immunity found throughout the body. Plasticity of macrophages is evidenced by alterations in phenotypic polarization in response to stimuli, and is associated with changes in effector molecules, receptor expression, and cytokine profile. M1-polarized macrophages are involved in pro-inflammatory responses while M2 macrophages are capable of anti-inflammatory response and tissue repair. Modulation of macrophages' activation state is an effective approach for several disease therapies, mediated by carbohydrate-coated nanocarriers. In this review, polymeric nanocarriers targeting macrophages are described in terms of production methods and conjugation strategies, highlighting the role of mannose receptor in the polarization of macrophages, and targeting approaches for infectious diseases, cancer immunotherapy, and prevention. Translation of this nanomedicine approach still requires further elucidation of the interaction mechanism between nanocarriers and macrophages towards clinical applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available